ReviewBiomolecules2024

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases.

Maria A Theodoropoulou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.